Neutrophil but not Monocyte Activation Inhibits P-Selectin-Mediated Platelet Adhesion^[*]

Summary

Selectins are Ca²⁺-dependent glycoprotein receptors that mediate the adhesion of activated platelets or endothelial cells to unstimulated leukocytes. Using purified cell fractions, we examined activated neutrophil adhesion to P-selectin-expressing platelets and found that phorbol 12-myristate 13-acetate (PMA), platelet activating factor C₁₆ (PAF), and n-formyl-met-leu-phe (fMLP) pretreatment of neutrophils inhibited activated platelet adhesion. Furthermore, PMA and PAF were capable of dissociating established resting neutrophil-activated platelet conjugates. Since L-selectin is downregulated after leukocyte activation and has been postulated as a ligand for P-selectin, we preincubated resting neutrophils with Dreg-2 and Dreg-56, blocking monoclonal antibodies (MoAb) to L-selectin; these MoAb failed to inhibit activated platelet adhesion. To more closely approximate in vivo conditions of leukocyte and platelet activation, we also employed a whole blood (WB) model of leukocyte-platelet adhesion. We found that simultaneous activation of both platelets and leukocytes by PMA caused an immediate rise in the % of P-selectin-positive platelets accompanied by a rapid increase in monocyte-platelet and neutrophil-platelet conjugates; however, the % of neutrophil-platelet conjugates subsequently declined over 30-60 min to baseline levels while monocyte-platelet adhesion remained elevated over 90 min. By contrast, selective platelet activation in WB by thrombin resulted in an increase in platelet P-selectin expression accompanied by a sustained (90 min) elevation in both monocyte- and neutrophil-platelet conjugates. This increase in leukocyte-platelet conjugates after thrombin was not inhibited by preincubation of WB with Dreg-2 or Dreg-56. We conclude that neutrophil activation decreases the expression of the ligand for platelet P-selectin within 30-60 min resulting in inhibition of neutrophil-platelet adhesion and dissociation of existing neutrophil-platelet conjugates. By contrast, monocyte activation over 90 min does not affect monocyte adhesion to activated platelets in whole blood.

^* Supported by grants HL02668 (HMR) and HL47193 (BRS) from the National Institutes of Health and the Donaghue Foundation (DL). CSR is a Clinician-Scientist of the American Heart Association., BRS is a Scholar of the Leukemia Society of America.

• References

• 1 Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554
• 2 Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312
• 3 Rinder HM, Bonan J, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991; 78: 1760-1769
• 4 Rinder HM, Bonan J, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78: 1730-1739
• 5 Geng J-G, Moore KL, Johnson AE, McEver RP. Pmn recognition requires a Ca conformational change in GMP140. J Biol Chem 1991; 266: 22313-22320
• 6 Geng JG, Heavner GA, McEver RP. Lectin domain peptides from selectins interact with both cell surface ligands and Ca²⁺ ions. J Biol Chem 1992; 267: 19846-19853
• 7 Moore K, Stults N, Diaz S, Smith D, Cummings R, Varki A, McEver R. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992; 118: 445-456
• 8 Skinner MP, Lucas CM, Bums GF, Chesterman CN, Bemdt MC. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 1991; 266: 5371-5374
• 9 Moore KL, Varki A, McEver RP. GMP-140 binds to a glycoprotein receptor on human neutrophils: evidence for a lectin-like interaction. J Cell Biol 1991; 112: 491-499
• 10 Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-873
• 11 Buttrum SM, Hatton R, Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 1993; 82: 1165-1174
• 12 Picker LJ, Warnock RA, Bums AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 1991; 66: 921-933
• 13 Berg M, James S. Human neutrophils release the Leu-8 lymph node homing receptor during cell activation. Blood 1990; 76: 2381-2386
• 14 Kishimoto T, Jutila M, Butcher E. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad USA 1990; 87: 2244-2252
• 15 Carmody M, Ault KA, Mitchell JG, Rote NS, Ng A. Production of monoclonal antibodies specific for platelet activation antigens and their use in evaluating platelet function. Hybridoma 1990; 9: 631-636
• 16 McGregor JL, Brochier J, Wild F, Follea G, Trezeciak MC, James E, Dechavanne M, McGregor L, Clemetson K. Monoclonal antibodies against platelet membrane glycoproteins. Eur J Biochem 1983; 131: 427-435
• 17 Von Andrian U, Chambers JD, Berg E, Michie S, Brown D, Karolak D, Ramezani L, Berger E, Arfors K, Butcher E. L-selectin mediates neutrophil rolling in inflamed venules through sialyl Lewisx-dependent and -independent recognition pathways. Blood 1993; 82: 182-191
• 18 Ley K, Tedder TF, Kansas GS. L-selectin can mediate leukocyte rolling in untreated mesenteric venules in vivo independent of E- or P-selectin. Blood 1993; 82: 1632-1638
• 19 Ross GD, Cain JA, Lachmann PJ. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol 1985; 134: 3307-3316
• 20 Phillips JH, Babcock GF. NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes. Immunol Lett 1983; 6: 143-150
• 21 Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R, Low EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein GPIMIIa with conformation-specific monoclonal antibodies. Blood 1990; 76: 2017-2023
• 22 Shen HH, Talle MA, Goldstein G, Chess L. Functional subsets of human monocytes defined by monoclonal antibodies; a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture. J Immunol 1983; 130: 698-705
• 23 Peerschke EI, Zucker MB. Fibrinogen receptor exposure and aggregation of human blood platelets produced by ADP and chilling. Blood 1981; 57: 663-670
• 24 Silverstein SL, Nachman RL. Thrombospondin binds to monocytes-macro-phages and mediates platelet-monocyte adhesion. J Clin Invest 1987; 79: 867-874
• 25 Spangenberg P, Redlich H, Bergmann I, Lösche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993; 70: 514-521
• 26 Beverley PCL. Production and use of monoclonal antibodies in transplantation immunology. In: Transplantation and Clinical Immunology XI Touraine JL, Träger J, Betuel H, Brochier J, Dubemard JM, Revillard JP, Triau R. eds Excerpta Medica; Amsterdam: 1980. pp 087-100
• 27 Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman TS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10: 448-456
• 28 Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediates throm-bospondin-dependent platelet-monocyte and platelet-U937 adhesion. J Clin Invest 1989; 84: 546-552
• 29 Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil MAC-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989; 245: 1238-1240
• 30 Kuijpers TW, Tool ATJ, van der Schoot CE, Ginsel LA, Onderwater JJM, Roos D, Verhoeven AJ. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78: 1105-1111
• 31 Huizinga TWJ, van der Schoot CE, Jost C, Klaasen R, Kleijer M, von dem Borne AEGK, Roos D, Tetteroo PAT. The Pi-linked receptor FcRIII is released on stimulation of neutrophils. Nature 1988; 333: 667-669
• 32 Tranqui L, Andrieux A, Hudry-Clergeon G, Ryckewaert JJ, Soyez S, Chapel A, Ginsberg MH, Plow EF, Marguerie G. Differential structural requirements for fibrinogen binding to platelets and endothelial cells. J Cell Biol 1989; 108: 2519-2526
• 33 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-132
• 34 Rinder H, Bonan J, Rinder C, Smith BR. Differences between leukocyte subsets with respect to platelet adhesion in whole blood. Blood 1991; 78 (Suppl) 185
• 35 Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 379-387
• 36 Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-1207
• 37 Zhou Q, Moore K, Smith D, Varki A, McEver R, Cummings R. The selectin GMP-140 binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells. J Cell Biol 1991; 115: 557-568
• 38 Polley M, Phillips ML, Wayner E, Nudelman E, Singhal A, Sen-Itiroh H, Paulson J. CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA 1991; 88: 6224-6228
• 39 Larsen G, Sako D, Ahem T, Shaffer M, Erban J, Sajer S, Gibson R, Wagner D, Furie BC, Furie B. P-selectin and E-selectin: distinct but overlapping leukocyte ligand specificities. J Biol Chem 1992; 267: 11104-11112
• 40 Norgard KE, Moore KL, Diaz S, Stults NL, Ushiyama S, McEver RP, Cummings RD, Varki A. Characterization of a specific ligand for P-selectin on myeloid cells. J Biol Chem 1993; 268: 12764-12774
• 41 Ley K, Linnemann G, Meinen M, Stoollam LM, Gaehtgens P. Fucoidin, but not yeast polyphosmannan PPME, inhibits leukocyte rolling in venules of the rat mesentery. Blood 1993; 81: 177-185
• 42 Corral L, Singer MS, Macher BA, Rosen SD. Requirement for sialic acid on neutrophils in a GMP-140 (PADGEM) mediated adhesive interaction with activated platelets. Biochem Biophys Res Comm 1990; 172: 1349-1355
• 43 Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 1988; 251: 293-299
• 44 Molino M, Di Lallo M, Martelli N, de Gaetano G, Cerletti C. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin. Blood 1993; 82: 2442-2451
• 45 Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379-2388
• 46 Evangelista V, Piccardoni P, White JG, de Gaetano G, Cerletti C. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin mediated cell-cell adhesion. Blood 1993; 81: 2947-2957
• 47 Palabrica T, Lobb T, Furie BC, Amovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851
• 48 Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31: 409-414
• 49 Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood 1990; 76: 1903-1910
• 50 Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993; 151: 3267-3276
• 51 Catlett R, Moore K, McEver RP, Morrissey JH. GMP-140 (CD62) induces tissue factor expression in monocytes. Blood 1991; 78 (Suppl) 72
• 52 Curtiss LK, Black AS, Takagi Y, Plow EF. New mechanism for foam cell generation in atherosclerotic lesions. J Clin Invest 1987; 80: 367-376